Searle auction coming?
The Monsanto board is reportedly considering splitting its pharmaceutical subsidiary Searle from its ag/bio business
You may also be interested in...
Merck will refrain from entering into co-promotion agreements to take advantage of its sales force capacity, CEO Raymond Gilmartin told securities analysts Dec. 9 at the company's Whitehouse Station, N.J. headquarters.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011